Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ann Marie Dvorak, M.D.

Co-Author

This page shows the publications co-authored by Ann Dvorak and Harold Dvorak.
Connection Strength

5.413
  1. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol. 1999; 237:97-132.
    View in: PubMed
    Score: 0.199
  2. Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels. Am J Pathol. 2017 Oct; 187(10):2337-2347.
    View in: PubMed
    Score: 0.180
  3. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol. 1996 Jan; 59(1):100-15.
    View in: PubMed
    Score: 0.161
  4. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995 May; 146(5):1029-39.
    View in: PubMed
    Score: 0.154
  5. Ultrastructural localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophage and line 10 hepatocarcinoma cell lipid bodies. Int Arch Allergy Immunol. 1993; 101(2):136-42.
    View in: PubMed
    Score: 0.131
  6. Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb Perspect Med. 2012 Feb; 2(2):a006544.
    View in: PubMed
    Score: 0.123
  7. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells. 1991 Mar; 3(3):77-85.
    View in: PubMed
    Score: 0.115
  8. Heterogeneity of the tumor vasculature. Semin Thromb Hemost. 2010 Apr; 36(3):321-31.
    View in: PubMed
    Score: 0.109
  9. Vascular permeability and pathological angiogenesis in caveolin-1-null mice. Am J Pathol. 2009 Oct; 175(4):1768-76.
    View in: PubMed
    Score: 0.104
  10. Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer. 2009 Mar 24; 100(6):865-9.
    View in: PubMed
    Score: 0.100
  11. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol. 1988 Oct; 133(1):95-109.
    View in: PubMed
    Score: 0.098
  12. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 2008; 11(2):109-19.
    View in: PubMed
    Score: 0.094
  13. Chapter 3. The adenoviral vector angiogenesis/lymphangiogenesis assay. Methods Enzymol. 2008; 444:43-64.
    View in: PubMed
    Score: 0.093
  14. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest. 1987 Dec; 57(6):673-86.
    View in: PubMed
    Score: 0.092
  15. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol. 2007; 2:251-75.
    View in: PubMed
    Score: 0.086
  16. Permeability properties of tumor surrogate blood vessels induced by VEGF-A. Lab Invest. 2006 Aug; 86(8):767-80.
    View in: PubMed
    Score: 0.083
  17. Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol. 1986 Feb; 17(2):122-37.
    View in: PubMed
    Score: 0.081
  18. Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium. J Histochem Cytochem. 2004 Jan; 52(1):87-101.
    View in: PubMed
    Score: 0.070
  19. VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med. 2003 Jul; 13(5):169-75.
    View in: PubMed
    Score: 0.068
  20. Basophil and mast cell degranulation: ultrastructural analysis of mechanisms of mediator release. Fed Proc. 1983 May 15; 42(8):2510-5.
    View in: PubMed
    Score: 0.067
  21. Cloned mouse cells with natural killer function and cloned suppressor T cells express ultrastructural and biochemical features not shared by cloned inducer T cells. J Exp Med. 1983 Mar 01; 157(3):843-61.
    View in: PubMed
    Score: 0.066
  22. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev. 1983; 2(1):41-73.
    View in: PubMed
    Score: 0.066
  23. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med. 2002 Dec 02; 196(11):1497-506.
    View in: PubMed
    Score: 0.065
  24. Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals. Microsc Res Tech. 2002 Jun 01; 57(5):289-326.
    View in: PubMed
    Score: 0.063
  25. Anaphylactic degranulation of guinea pig basophilic leukocytes. II. Evidence for regranulation of mature basophils during recovery from degranulation in vitro. Lab Invest. 1982 May; 46(5):461-75.
    View in: PubMed
    Score: 0.063
  26. VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations. Cold Spring Harb Symp Quant Biol. 2002; 67:227-37.
    View in: PubMed
    Score: 0.061
  27. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol. 2001 Mar; 158(3):1145-60.
    View in: PubMed
    Score: 0.058
  28. Anaphylactic degranulation of guinea pig basophilic leukocytes. I. Fusion of granule membranes and cytoplasmic vesicles formation and resolution of degranulation sacs. Lab Invest. 1981 Feb; 44(2):174-91.
    View in: PubMed
    Score: 0.057
  29. A role for cytoplasmic vesicles in anaphylactic degranulation of guinea pig basophils. Int Arch Allergy Appl Immunol. 1981; 66 Suppl 1:234-8.
    View in: PubMed
    Score: 0.057
  30. Melanoma. An ultrastructural study of the host inflammatory and vascular responses. J Invest Dermatol. 1980 Nov; 75(5):388-93.
    View in: PubMed
    Score: 0.056
  31. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem. 2000 Apr; 48(4):545-56.
    View in: PubMed
    Score: 0.054
  32. Ultrastructural studies of macrophages: in vitro removal of cell coat with macrophage inhibition factor (MIF)-containing lymphocyte culture supernatants; chloroform extraction, phospholipase digestion, and autoradiographic studies. J Reticuloendothel Soc. 1980 Feb; 27(2):119-42.
    View in: PubMed
    Score: 0.054
  33. Evidence for a vesicular transport mechanism in guinea pig basophilic leukocytes. Lab Invest. 1980 Feb; 42(2):263-76.
    View in: PubMed
    Score: 0.054
  34. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res. 2000 Jan; 59(1):24-37.
    View in: PubMed
    Score: 0.053
  35. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest. 2000 Jan; 80(1):99-115.
    View in: PubMed
    Score: 0.053
  36. Expression of cell-mediated hypersensitivity in vivo--recent advances. Int Rev Exp Pathol. 1980; 21:119-94.
    View in: PubMed
    Score: 0.053
  37. The basophil. Its morphology, biochemistry, motility, release reactions, recovery, and role in the inflammatory responses of IgE-mediated and cell-mediated origin. Arch Pathol Lab Med. 1979 Oct; 103(11):551-7.
    View in: PubMed
    Score: 0.052
  38. Tumor-basophil interactions in vitro--a scanning and transmission electron microscopic study. J Immunol. 1979 Jun; 122(6):2447-57.
    View in: PubMed
    Score: 0.051
  39. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation. 1999 Mar; 6(1):23-44.
    View in: PubMed
    Score: 0.050
  40. Ultrastructure of the cell coat of untransformed and simian virus 40-transformed fibroblasts. J Reticuloendothel Soc. 1979 Feb; 25(2):163-77.
    View in: PubMed
    Score: 0.050
  41. Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels. J Histochem Cytochem. 1999 Feb; 47(2):159-67.
    View in: PubMed
    Score: 0.050
  42. Plasminogen activator of guinea pig basophils. A protease probably localized to the cell surface. Monogr Allergy. 1979; 14:249-52.
    View in: PubMed
    Score: 0.050
  43. Platelets exit venules by a transcellular pathway at sites of F-met peptide-induced acute inflammation in guinea pigs. Int Arch Allergy Immunol. 1998 Jul; 116(3):188-95.
    View in: PubMed
    Score: 0.048
  44. Immunologic rejection of mammary adenocarcinoma (TA3-St) in C57BL/6 mice: participation of neutrophils and activated macrophages with fibrin formation. J Immunol. 1978 Apr; 120(4):1240-8.
    View in: PubMed
    Score: 0.047
  45. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med. 1998 Mar 16; 187(6):903-15.
    View in: PubMed
    Score: 0.047
  46. Plasminogen activator of guinea pig basophilic leukocytes: probable localization to the plasma membrane. J Immunol. 1978 Mar; 120(3):766-73.
    View in: PubMed
    Score: 0.047
  47. Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea-pig, mouse and rat: many are transcellular pores. J Physiol. 1997 Nov 01; 504 ( Pt 3):747-61.
    View in: PubMed
    Score: 0.046
  48. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS. 1997; 79:233-69.
    View in: PubMed
    Score: 0.043
  49. Ultrastructural immunogold localization of osteopontin in human gastric mucosa. J Histochem Cytochem. 1997 Jan; 45(1):21-33.
    View in: PubMed
    Score: 0.043
  50. Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factor. Eur J Cancer. 1996 Dec; 32A(14):2467-73.
    View in: PubMed
    Score: 0.043
  51. Morphology of delayed-type hypersensitivity reactions in man. J Invest Dermatol. 1976 Sep; 67(3):391-401.
    View in: PubMed
    Score: 0.042
  52. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med. 1996 May 01; 183(5):1981-6.
    View in: PubMed
    Score: 0.041
  53. Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J Immunol. 1976 Mar; 116(3):687-95.
    View in: PubMed
    Score: 0.041
  54. Degranulation mechanisms in human leukemic basophils. Clin Immunol Immunopathol. 1976 Mar; 5(2):235-46.
    View in: PubMed
    Score: 0.041
  55. Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab Invest. 1976 Feb; 34(2):179-91.
    View in: PubMed
    Score: 0.041
  56. Basophilic leucocytes: structure, function and role in disease. Clin Haematol. 1975 Oct; 4(3):651-83.
    View in: PubMed
    Score: 0.040
  57. Intracellular distribution of TM4SF1 and internalization of TM4SF1-antibody complex in vascular endothelial cells. Biochem Biophys Res Commun. 2015 Sep 25; 465(3):338-43.
    View in: PubMed
    Score: 0.039
  58. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem. 1995 Apr; 43(4):381-9.
    View in: PubMed
    Score: 0.038
  59. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res. 1995 Jan 15; 55(2):376-85.
    View in: PubMed
    Score: 0.038
  60. TM4SF1: a new vascular therapeutic target in cancer. Angiogenesis. 2014 Oct; 17(4):897-907.
    View in: PubMed
    Score: 0.036
  61. Structure of Freund's complete and incomplete adjuvants. Relation of adjuvanticity to structure. Immunology. 1974 Jul; 27(1):99-114.
    View in: PubMed
    Score: 0.036
  62. Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells. J Histochem Cytochem. 1994 Mar; 42(3):351-61.
    View in: PubMed
    Score: 0.036
  63. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 1993 Sep; 12(3-4):303-24.
    View in: PubMed
    Score: 0.034
  64. Fibroblast migration in fibrin gel matrices. Am J Pathol. 1993 Jan; 142(1):273-83.
    View in: PubMed
    Score: 0.033
  65. Basophilic leukocytes in delayed-type hypersensitivity reactions in experimental animals and man. Adv Exp Med Biol. 1973; 29(0):573-9.
    View in: PubMed
    Score: 0.033
  66. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci. 1992 Dec 04; 667:101-11.
    View in: PubMed
    Score: 0.033
  67. Basophils, mast cells, and cellular immunity in animals and man. Hum Pathol. 1972 Dec; 3(4):454-6.
    View in: PubMed
    Score: 0.033
  68. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest. 1992 Nov; 67(5):596-607.
    View in: PubMed
    Score: 0.032
  69. Revealing the role of phospholipase Cß3 in the regulation of VEGF-induced vascular permeability. Blood. 2012 Sep 13; 120(11):2167-73.
    View in: PubMed
    Score: 0.032
  70. Morphologic changes in draining lymph nodes and in lymphocyte cultures after sensitization with complete or incomplete Freund's adjuvant. Correlation with immunologic events in vivo and in culture. J Immunol. 1971 Aug; 107(2):422-35.
    View in: PubMed
    Score: 0.030
  71. TM4SF1: a tetraspanin-like protein necessary for nanopodia formation and endothelial cell migration. Angiogenesis. 2011 Sep; 14(3):345-54.
    View in: PubMed
    Score: 0.029
  72. Cytoplasmic lipid bodies of human eosinophils. Subcellular isolation and analysis of arachidonate incorporation. Am J Pathol. 1991 Jan; 138(1):141-8.
    View in: PubMed
    Score: 0.029
  73. Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease. Am Rev Respir Dis. 1989 Oct; 140(4):1104-7.
    View in: PubMed
    Score: 0.026
  74. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta. 1989 Feb; 948(3):305-26.
    View in: PubMed
    Score: 0.025
  75. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. J Immunol. 1988 Apr 01; 140(7):2340-9.
    View in: PubMed
    Score: 0.024
  76. Transcellular diapedesis is initiated by invasive podosomes. Immunity. 2007 Jun; 26(6):784-97.
    View in: PubMed
    Score: 0.022
  77. Nonspecific esterase activity expressed in Weibel-Palade bodies of cloned guinea pig aortic endothelial cells. J Histochem Cytochem. 1987 May; 35(5):531-9.
    View in: PubMed
    Score: 0.022
  78. Ultrastructural cytochemical and autoradiographic demonstration of nonspecific esterase(s) in guinea pig basophils. J Histochem Cytochem. 1987 Mar; 35(3):351-60.
    View in: PubMed
    Score: 0.022
  79. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell. 2006 Aug; 10(2):159-70.
    View in: PubMed
    Score: 0.021
  80. Macrophage migration in fibrin gel matrices. Lab Invest. 1986 Jan; 54(1):62-70.
    View in: PubMed
    Score: 0.020
  81. Circulating membrane vesicles in leukemic blood. Cancer Res. 1985 Nov; 45(11 Pt 2):5944-51.
    View in: PubMed
    Score: 0.020
  82. Regulation of extravascular coagulation by microvascular permeability. Science. 1985 Mar 01; 227(4690):1059-61.
    View in: PubMed
    Score: 0.019
  83. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell. 2005 Mar; 7(3):251-61.
    View in: PubMed
    Score: 0.019
  84. Surface membrane traffic in guinea pig basophils exposed to cationic ferritin. Int Arch Allergy Appl Immunol. 1985; 77(1-2):267-73.
    View in: PubMed
    Score: 0.019
  85. Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation. J Cell Biol. 1984 Nov; 99(5):1678-87.
    View in: PubMed
    Score: 0.019
  86. Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog Allergy. 1984; 34:1-141.
    View in: PubMed
    Score: 0.018
  87. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J Immunol. 1983 Dec; 131(6):2965-76.
    View in: PubMed
    Score: 0.017
  88. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res. 1983 Sep; 43(9):4434-42.
    View in: PubMed
    Score: 0.017
  89. Ultrastructural criteria for identification of mast cells and basophils in humans, guinea pigs, and mice. Am Rev Respir Dis. 1983 Aug; 128(2 Pt 2):S49-52.
    View in: PubMed
    Score: 0.017
  90. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 2003 Jul 15; 22(14):3546-56.
    View in: PubMed
    Score: 0.017
  91. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983 Feb 25; 219(4587):983-5.
    View in: PubMed
    Score: 0.017
  92. Mouse mast cells and other granulated leukocyte clones. Ultrastructure of cloned mouse leukocytes. Monogr Allergy. 1983; 18:129-37.
    View in: PubMed
    Score: 0.016
  93. Mouse mast cell clones: modulation of functional maturity in vitro. Monogr Allergy. 1983; 18:166-70.
    View in: PubMed
    Score: 0.016
  94. Mast cell clones: a model for the analysis of cellular maturation. J Cell Biol. 1982 Nov; 95(2 Pt 1):435-44.
    View in: PubMed
    Score: 0.016
  95. Defective associations between blood vessels and brain parenchyma lead to cerebral hemorrhage in mice lacking alphav integrins. Mol Cell Biol. 2002 Nov; 22(21):7667-77.
    View in: PubMed
    Score: 0.016
  96. A cloned cell with NK function resembles basophils by ultrastructure and expresses IgE receptors. Nature. 1982 Jul 15; 298(5871):288-90.
    View in: PubMed
    Score: 0.016
  97. Fibrin deposits in Hodgkin's disease. Am J Pathol. 1982 Jul; 108(1):119-29.
    View in: PubMed
    Score: 0.016
  98. Ultrastructural identification of the mouse basophil. Blood. 1982 Jun; 59(6):1279-85.
    View in: PubMed
    Score: 0.016
  99. Ultrastructural localization of nonspecific esterase activity in guinea pig and human monocytes, macrophages, and lymphocytes. Blood. 1981 Dec; 58(6):1089-99.
    View in: PubMed
    Score: 0.015
  100. Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. J Natl Cancer Inst. 1981 Aug; 67(2):335-45.
    View in: PubMed
    Score: 0.015
  101. Surface membrane alterations in guinea pig basophils undergoing anaphylactic degranulation. A scanning electron microscopic study. Lab Invest. 1981 Jul; 45(1):58-66.
    View in: PubMed
    Score: 0.015
  102. Tumor shedding and coagulation. Science. 1981 May 22; 212(4497):923-4.
    View in: PubMed
    Score: 0.015
  103. Guinea pig basophil morphology in vitro. I. Ultrastructure of uropod-bearing (motile) basophils and modulation of motile structures by serum and substrate effects. J Immunol. 1981 Mar; 126(3):1066-74.
    View in: PubMed
    Score: 0.014
  104. Glycosaminoglycans and proteases of guinea pig basophilic leukocytes. Kroc Found Ser. 1981; 14:123-43.
    View in: PubMed
    Score: 0.014
  105. Antigen-induced IgE-mediated degranulation of human basophils. Lab Invest. 1980 Aug; 43(2):126-39.
    View in: PubMed
    Score: 0.014
  106. The microvasculature is the critical target of the immune response in vascularized skin allograft rejection. J Invest Dermatol. 1980 May; 74(5):280-4.
    View in: PubMed
    Score: 0.014
  107. Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med. 1979 Aug 01; 150(2):322-37.
    View in: PubMed
    Score: 0.013
  108. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J Natl Cancer Inst. 1979 Jun; 62(6):1459-72.
    View in: PubMed
    Score: 0.013
  109. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol. 1979 Jan; 122(1):166-74.
    View in: PubMed
    Score: 0.012
  110. Preparation of a rabbit anti-guinea pig basophil serum: in vitro and in vivo characterization. J Immunol. 1978 Sep; 121(3):1157-66.
    View in: PubMed
    Score: 0.012
  111. Sulfated glycosaminoglycans of guinea pig basophilic leukocytes. J Immunol. 1978 Aug; 121(2):586-92.
    View in: PubMed
    Score: 0.012
  112. Effect of E-amino caproic acid on macrohage cell coat and migration inhibtion. J Reticuloendothel Soc. 1978 Jul; 24(1):63-72.
    View in: PubMed
    Score: 0.012
  113. Patients without basophils. Lancet. 1977 Aug 20; 2(8034):409.
    View in: PubMed
    Score: 0.011
  114. Isolation of the cytoplasmic granules of guinea pig basophilic leukocytes: identification of esterase and protease activities. J Immunol. 1977 Jul; 119(1):38-46.
    View in: PubMed
    Score: 0.011
  115. Metabolic studies of guinea pig basophilic leukocytes in short-term tissue culture. I. Measurement of histaminesynthesizing capacity by using an isotopic-thin layer chromatographic assay. J Immunol. 1976 Oct; 117(4):1085-92.
    View in: PubMed
    Score: 0.011
  116. Purification of basophilic leukocytes from guinea pig blood and bone marrow. J Immunol. 1974 Dec; 113(6):1694-702.
    View in: PubMed
    Score: 0.009
  117. MIF-like activity in simian virus 40-transformed 3T3 fibroblast cultures. Science. 1974 Sep 13; 185(4155):955-7.
    View in: PubMed
    Score: 0.009
  118. Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest. 1974 Aug; 31(2):111-30.
    View in: PubMed
    Score: 0.009
  119. Mast cells in the cortical tubular epithelium and interstitium in human renal disease. Hum Pathol. 1974 May; 5(3):315-26.
    View in: PubMed
    Score: 0.009
  120. Proceedings: Morphologic studies in cellular hypersensitivity in guinea pigs and man. Monogr Allergy. 1974; 8(0):54-65.
    View in: PubMed
    Score: 0.009
  121. Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates. J Exp Med. 1973 Mar 01; 137(3):751-75.
    View in: PubMed
    Score: 0.008
  122. Loss of cell surface material from peritoneal exudate cells associated with lymphocyte-mediated inhibition of macrophage migration from capillary tubes. Lab Invest. 1972 Dec; 27(6):561-74.
    View in: PubMed
    Score: 0.008
  123. Cytochemical localization of peroxidase activity in the developing erythrocyte. Am J Pathol. 1972 May; 67(2):303-26.
    View in: PubMed
    Score: 0.008
  124. Uptake of horseradish peroxidase by guinea pig basophilic leukocytes. Lab Invest. 1972 Jan; 26(1):27-39.
    View in: PubMed
    Score: 0.008
  125. Cutaneous basophil hypersensitivity. II. A light and electron microscopic description. J Exp Med. 1970 Sep 01; 132(3):558-82.
    View in: PubMed
    Score: 0.007
  126. Inbred guinea pig aortic endothelial cell clones. Model for studying the vascular endothelium under totally isologous conditions. Lab Invest. 1986 Dec; 55(6):703-16.
    View in: PubMed
    Score: 0.005
  127. Differences in the volume distributions of human lung mast cell granules and lipid bodies: evidence that the size of these organelles is regulated by distinct mechanisms. J Cell Biol. 1985 May; 100(5):1488-92.
    View in: PubMed
    Score: 0.005
  128. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature. 1981 May 28; 291(5813):332-4.
    View in: PubMed
    Score: 0.004
  129. Generation of macrophage migration inhibitory activity by plasminogen activators. Proc Natl Acad Sci U S A. 1977 Apr; 74(4):1570-4.
    View in: PubMed
    Score: 0.003
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.